A carregar...
PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma
Checkpoint inhibitors are revolutionizing treatment options and expectations for patients with melanoma. Ipilimumab, a monoclonal antibody against cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4), was the first approved checkpoint inhibitor. Emerging long-term data indicate that approximately 20...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4414130/ https://ncbi.nlm.nih.gov/pubmed/25682878 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|